mirapharmaceuticals.com (MIRA): Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

MIRA Pharmaceuticals (MIRA) bases its research in Florida, delegating the synthesis of compounds to third-party certified enterprises. This neuropsychological model allows the company to scale global sales upon the success of a single drug, ensuring colossal revenue. The EV/EBITDA market trend, visualized in monetary terms, stands at 0.00, while the company relies on a lean staff of scientists, outsourcing all testing to external contractors.

MIRA MIRA Pharmaceuticals Inc.: Enterprise Value to EBITDA Ratio in the range 11/23/2025 - 11/14/2026

Analytical breakdowns for MIRA Pharmaceuticals

- current price and projected stock value:

Stock Price MIRA Pharmaceuticals, Inc.|MIRA - Analyst Consensus Forecast

- stock exchange capitalization data:

Market Value MIRA Pharmaceuticals, Inc.|MIRA - Value Adjusted for Debt and Cash

- book value of equity indicators:

Net Assets per Single Share MIRA Pharmaceuticals|MIRA - Company Net Assets|Market Value to Book Value Ratio mirapharmaceuticals.com|MIRA - Cumulative Company Assets

- debt and solvency information:

Total Debt to Capital MIRA Pharmaceuticals|MIRA - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity MIRA Pharmaceuticals, Inc.|MIRA - Aggregate Debt Obligations|Debts to Book Capitalization MIRA Pharmaceuticals, Inc.|MIRA - Company Long-Term Debts|Company Current Liabilities MIRA Pharmaceuticals|Quick Liquidity mirapharmaceuticals.com

- business earnings and investment ratios data:

MIRA - Profit After Tax|Projected Future Earnings MIRA Pharmaceuticals|MIRA - Company Value to Net Income|Forward P/E Multiple MIRA Pharmaceuticals, Inc.|MIRA - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization MIRA Pharmaceuticals, Inc.|MIRA - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months MIRA Pharmaceuticals|MIRA - Net earnings per share for the last 12 months|Quarterly EPS earnings growth mirapharmaceuticals.com|MIRA - Earnings growth in current year|Earnings growth forecast for next year MIRA Pharmaceuticals

- sales and revenue data:

MIRA - Company Sales|Projected Sales Volume MIRA Pharmaceuticals, Inc.|MIRA - Price to Sales|Forward Price-to-Revenue Multiple MIRA Pharmaceuticals, Inc.

Summary company analysis:MIRA Pharma MIRA

Product sample of MIRA Pharmaceuticals, Inc.

This indicator determines the ratio of total enterprise value to operating profit before depreciation and amortization, allowing for an assessment of capital management efficiency and debt load. By analyzing the current EV/EBITDA multiple of MIRA Pharmaceuticals (MIRA), an investor determines the degree of overpayment for the asset, which is critical for MIRA Pharmaceuticals during a period of intensive R&D expenditures on the synthesis of innovative non-opioid drugs.

Competitors of MIRA Pharmaceuticals

EV/EBITDA Multiple INDV (Indivior Group)|EV/EBITDA Multiple Collegium Corp COLL|CRON - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation CGC (canopygrowth.com)|High Tide (HITI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Aurora Cannabis Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Achieve Life Sciences, Inc|Enterprise Value to EBITDA Ratio skyebioscience.com (SKYE)|EV/EBITDA Multiple ANEB|Total Company Value to Operating Income Before Depreciation Ratio intercure.co|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nutriband NTRB|Business Value to Operating Income Before Depreciation NSRX|IGC Pharma Inc - EV/EBITDA Multiple|FLGC - EV/EBITDA Multiple|IMCC (imcannabis.com) - Enterprise Value to EBITDA Ratio|Adial Pharmaceuticals, Inc. - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artelo Biosciences Inc.|Ensysce - Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple TTNP|GNLN (Greenlane Corp) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple INM (InMed Pharmaceuticals)|EV/EBITDA Multiple akandacorp.com AKAN|ENVB - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation BGXX (Bright Green)|Hempacco (HPCO) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization